Bio-Techne (TECH) is scheduled to report Q4 earnings on August 5, 2026. Analysts estimate EPS of $0.52 and quarterly revenue of $317.21M.
In the most recent quarter (Q3), Bio-Techne reported EPS of $0.53, beating estimates of $0.52 by 0.02%. Revenue came in at $311.42M, missing the estimate of $316.63M by 0.02%.
Bio-Techne has beaten EPS estimates in 7 consecutive quarters.
Over the last 4 quarters, Bio-Techne has averaged an EPS surprise of 0.08% and a revenue surprise of 0.01%.
Analyze the earnings history of Bio-Techne using advanced sorting and filters.
The chart below shows Bio-Techne's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Bio-Techne's reported revenue compared to analyst estimates over recent quarters.
Bio-Techne (TECH) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 6, 2026 for Q3.
The Actual EPS was $0.53, which beat the estimate of $0.52.
The Actual Revenue was $311.42M, which missed the estimate of $316.63M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2026-05-06 | $0.53 | $0.52 | 1.92 % |
| Q2 | 2026-02-04 | $0.46 | $0.40 | 15.0 % |
| Q1 | 2025-11-05 | $0.42 | $0.40 | 5.00 % |
| Q4 | 2025-08-06 | $0.53 | $0.48 | 10.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2026-05-06 | $311.42M | $316.63M | -1.65 % |
| Q2 | 2026-02-04 | $295.88M | $291.09M | 1.64 % |
| Q1 | 2025-11-05 | $286.56M | $290.54M | -1.37 % |
| Q4 | 2025-08-06 | $316.96M | $315.78M | 0.38 % |